241 related articles for article (PubMed ID: 32207590)
1. Veno-occlusive disease in children and adolescents after hematopoietic stem cell transplantation: Did the Modified Seattle Criteria fit the characteristics of pediatric population?
Szmit Z; Gorczyńska E; Mielcarek-Siedziuk M; Ussowicz M; Owoc-Lempach J; Kałwak K
Adv Clin Exp Med; 2020 Mar; 29(3):339-344. PubMed ID: 32207590
[TBL] [Abstract][Full Text] [Related]
2. Hepatic veno-occlusive disease in pediatric stem cell transplantation: impact of pre-emptive antithrombin III replacement and combined antithrombin III/defibrotide therapy.
Haussmann U; Fischer J; Eber S; Scherer F; Seger R; Gungor T
Haematologica; 2006 Jun; 91(6):795-800. PubMed ID: 16769582
[TBL] [Abstract][Full Text] [Related]
3. Incidence of Anicteric Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome and Outcomes with Defibrotide following Hematopoietic Cell Transplantation in Adult and Pediatric Patients.
Corbacioglu S; Kernan NA; Pagliuca A; Ryan RJ; Tappe W; Richardson PG
Biol Blood Marrow Transplant; 2020 Jul; 26(7):1342-1349. PubMed ID: 32200121
[TBL] [Abstract][Full Text] [Related]
4. Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease after Autologous or Allogeneic Hematopoietic Stem Cell Transplantation in Children: a retrospective study of the Italian Hematology-Oncology Association-Hematopoietic Stem Cell Transplantation Group.
Faraci M; Bertaina A; Luksch R; Calore E; Lanino E; Saglio F; Prete A; Menconi M; De Simone G; Tintori V; Cesaro S; Santarone S; Orofino MG; Locatelli F; Zecca M
Biol Blood Marrow Transplant; 2019 Feb; 25(2):313-320. PubMed ID: 30266674
[TBL] [Abstract][Full Text] [Related]
5. BCSH/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation.
Dignan FL; Wynn RF; Hadzic N; Karani J; Quaglia A; Pagliuca A; Veys P; Potter MN; ;
Br J Haematol; 2013 Nov; 163(4):444-57. PubMed ID: 24102514
[TBL] [Abstract][Full Text] [Related]
6. Introduction of new pediatric EBMT criteria for VOD diagnosis: is it time-saving or money-wasting? : Prospective evaluation of pediatric EBMT criteria for VOD.
Szmit Z; Gorczynska E; Król A; Ussowicz M; Mielcarek-Siedziuk M; Olejnik I; Panasiuk A; Kałwak K
Bone Marrow Transplant; 2020 Nov; 55(11):2138-2146. PubMed ID: 32398785
[TBL] [Abstract][Full Text] [Related]
7. Retrospective Application of Sinusoidal Obstruction Syndrome/Veno-occlusive Disease Diagnostic Criteria in a Pediatric Hematopoietic Stem Cell Transplant Cohort.
Dhir A; Wadhwa A; Haines H; Chewning J; Murthy S; Kim J; Beatty L; Mixon E; Fowler KB; Gage J; Meadows T; Goldman F
J Pediatr Hematol Oncol; 2022 Mar; 44(2):e343-e348. PubMed ID: 35200220
[TBL] [Abstract][Full Text] [Related]
8. Ultrasound in Hepatic Veno-occlusive Disease (HVOD) after Pediatric Hematopoietic Stem Cell Transplantation (HSCT): Comparison of Diagnostic Criteria Including the Pediatric Criteria of European Society for Blood and Marrow Transplantation (EBMT).
Chung H; Im SA; Kim SK
Pediatr Hematol Oncol; 2020 May; 37(4):275-287. PubMed ID: 32131664
[TBL] [Abstract][Full Text] [Related]
9. Defibrotide for Patients with Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome: Interim Results from a Treatment IND Study.
Richardson PG; Smith AR; Triplett BM; Kernan NA; Grupp SA; Antin JH; Lehmann L; Shore T; Iacobelli M; Miloslavsky M; Hume R; Hannah AL; Nejadnik B; Soiffer RJ;
Biol Blood Marrow Transplant; 2017 Jun; 23(6):997-1004. PubMed ID: 28285079
[TBL] [Abstract][Full Text] [Related]
10. Veno-occlusive disease of the liver in the absence of elevation in bilirubin in pediatric patients after hematopoietic stem cell transplantation.
Myers KC; Dandoy C; El-Bietar J; Davies SM; Jodele S
Biol Blood Marrow Transplant; 2015 Feb; 21(2):379-81. PubMed ID: 25300869
[TBL] [Abstract][Full Text] [Related]
11. Validation of treatment outcomes according to revised severity criteria from European Society for Blood and Marrow Transplantation (EBMT) for sinusoidal obstruction syndrome/veno-occlusive disease (SOS/VOD).
Yoon JH; Yoo KH; Sung KW; Jung CW; Kim JS; Hahn SM; Kang HJ; Lee JH; Im HJ; Ahn JS; Kook H; Cho B; Lee JW
Bone Marrow Transplant; 2019 Aug; 54(8):1361-1368. PubMed ID: 30809031
[TBL] [Abstract][Full Text] [Related]
12. Liver Stiffness Measurement Allows Early Diagnosis of Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome in Adult Patients Who Undergo Hematopoietic Stem Cell Transplantation: Results from a Monocentric Prospective Study.
Colecchia A; Ravaioli F; Sessa M; Alemanni VL; Dajti E; Marasco G; Vestito A; Zagari RM; Barbato F; Arpinati M; Cavo M; Festi D; Bonifazi F
Biol Blood Marrow Transplant; 2019 May; 25(5):995-1003. PubMed ID: 30660772
[TBL] [Abstract][Full Text] [Related]
13. Prophylactic low-dose heparin or prostaglandin E1 may prevent severe veno-occlusive disease of the liver after allogeneic hematopoietic stem cell transplantation in Korean children.
Song JS; Seo JJ; Moon HN; Ghim T; Im HJ
J Korean Med Sci; 2006 Oct; 21(5):897-903. PubMed ID: 17043426
[TBL] [Abstract][Full Text] [Related]
14. Transjugular Intrahepatic Portosystemic Shunt for Very Severe Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) after Unmanipulated Haploidentical Hematopoietic Stem Cell Transplantation with Post-transplantation Cyclophosphamide.
Gómez-Centurión I; Bailén R; Oarbeascoa G; Muñoz C; Luque AÁ; Boyra ME; Calleja E; Rincón D; Dorado N; Barzallo P; Anguita J; Díez-Martín JL; Kwon M
Biol Blood Marrow Transplant; 2020 Nov; 26(11):2089-2097. PubMed ID: 32791193
[TBL] [Abstract][Full Text] [Related]
15. Role of Initiating Supportive Care Preceding Veno-occlusive Disease Diagnosis Following Allogeneic Hematopoietic Stem Cell Transplantation in Children.
Rayner P; Spruit JL; Chu R; Yankelevich M; Henry M; Ravindranath Y; Savaşan S
J Pediatr Hematol Oncol; 2019 Aug; 41(6):e395-e401. PubMed ID: 30933024
[TBL] [Abstract][Full Text] [Related]
16. Contribution of fibrinolytic tests to the differential diagnosis of veno-occlusive disease complicating pediatric hematopoietic stem cell transplantation.
Sartori MT; Cesaro S; Peruzzo M; Messina C; Saggiorato G; Calore E; Pillon M; Varotto S; Spiezia L; Cella G
Pediatr Blood Cancer; 2012 May; 58(5):791-7. PubMed ID: 21674760
[TBL] [Abstract][Full Text] [Related]
17. The incidence and risk factors of hepatic veno-occlusive disease after hematopoietic stem cell transplantation in Taiwan.
Lee CC; Chang HH; Lu MY; Yang YL; Chou SW; Lin DT; Jou ST; Yao M; Li CC; Yeh SP; Chen MH; Gau JP; Li SS; Wang PN; Liu YC; Wang TF; Tan TD; Lee MY; Yu MS; Wang CC; Lin SC; Chen YC; Su YC; Su KY; Lin KH
Ann Hematol; 2019 Mar; 98(3):745-752. PubMed ID: 30666432
[TBL] [Abstract][Full Text] [Related]
18. The incidence of veno-occlusive disease following allogeneic hematopoietic stem cell transplantation has diminished and the outcome improved over the last decade.
Carreras E; Díaz-Beyá M; Rosiñol L; Martínez C; Fernández-Avilés F; Rovira M
Biol Blood Marrow Transplant; 2011 Nov; 17(11):1713-20. PubMed ID: 21708110
[TBL] [Abstract][Full Text] [Related]
19. Busulfan clearance does not predict the development of hepatic veno-occlusive disease in patients undergoing hematopoietic stem cell transplantation.
Salman B; Al-Khabori M; Al-Huneini M; Al-Rawas A; Dennison D; Al-Za'abi M
Int J Hematol; 2020 Aug; 112(2):210-216. PubMed ID: 32468179
[TBL] [Abstract][Full Text] [Related]
20. High-dose methylprednisolone for veno-occlusive disease of the liver in pediatric hematopoietic stem cell transplantation recipients.
Myers KC; Lawrence J; Marsh RA; Davies SM; Jodele S
Biol Blood Marrow Transplant; 2013 Mar; 19(3):500-3. PubMed ID: 23211838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]